PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. They do not have biosimilar or generic competition available in the market.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Healthcare Success

NOVEMBER 7, 2022

According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. For example, pharma marketers can track and attribute increased prescriptions to specific ad campaigns. Your ads should be streaming, too.

Marketing 52

Marketing Media Healthcare Healthcare 52

Celeritas

NOVEMBER 7, 2022

billion by 2025. Prescriptive Analytics: . The provision of a competitive advantage over other dairy suppliers also plays a major role in the considerations. Automated cleaning systems improve hygiene to lower the risk of infection and facilitate the ease of access for waste removal machinery. Effort Expectancy.

Networking 52

Networking Pharmaceutical products Management Transportation 52

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. Drug manufacturers should prepare formulary access and contracting strategies that consider the implications of the IRA through 2025 and beyond. The IRA affects several components of the U.S.

Government 97

Government Manufacturing Prescription Marketing 97

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Clarivate

OCTOBER 17, 2024

Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. Such a change would sharply increase the number of people covered under this program.

Healthcare 52

Healthcare Healthcare Government Insurance 52